BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12000215)

  • 1. Sleep apnea associated with antipsychotic-induced obesity.
    Wirshing DA; Pierre JM; Wirshing WC
    J Clin Psychiatry; 2002 Apr; 63(4):369-70. PubMed ID: 12000215
    [No Abstract]   [Full Text] [Related]  

  • 2. Schizophrenia, obesity, and obstructive sleep apnea.
    Winkelman JW
    J Clin Psychiatry; 2001 Jan; 62(1):8-11. PubMed ID: 11235938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight gain and antipsychotic medications.
    Aquila R; Emanuel M
    J Clin Psychiatry; 1999 May; 60(5):336-7. PubMed ID: 10362443
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of initial antipsychotic response to clozapine and long-term weight gain.
    Bai YM; Lin CC; Chen JY; Lin CY; Su TP; Chou P
    Am J Psychiatry; 2006 Jul; 163(7):1276-9. PubMed ID: 16816235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight gain with clozapine compared to first generation antipsychotic medications.
    Covell NH; Weissman EM; Essock SM
    Schizophr Bull; 2004; 30(2):229-40. PubMed ID: 15279042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine and weight gain.
    Theisen FM; Cichon S; Linden A; Martin M; Remschmidt H; Hebebrand J
    Am J Psychiatry; 2001 May; 158(5):816. PubMed ID: 11329412
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive behavior therapy for weight gain.
    Umbricht D; Flury H; Bridler R
    Am J Psychiatry; 2001 Jun; 158(6):971. PubMed ID: 11384925
    [No Abstract]   [Full Text] [Related]  

  • 8. [Expectations and developments in atypical antipsychotics].
    Praxis (Bern 1994); 2004 Aug; 93(35):1392. PubMed ID: 15468579
    [No Abstract]   [Full Text] [Related]  

  • 9. Schizophrenia, antipsychotics, and the metabolic syndrome: is there a silver lining?
    Remington G
    Am J Psychiatry; 2006 Jul; 163(7):1132-4. PubMed ID: 16816213
    [No Abstract]   [Full Text] [Related]  

  • 10. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
    Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
    J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.
    Siskind D; Friend N; Russell A; McGrath JJ; Lim C; Patterson S; Flaws D; Stedman T; Moudgil V; Sardinha S; Suetani S; Kisely S; Winckel K; Baker A
    BMJ Open; 2018 Mar; 8(3):e021000. PubMed ID: 29500217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
    Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
    J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication-induced weight gain and dyslipidemia in patients with schizophrenia.
    Fenton WS; Chavez MR
    Am J Psychiatry; 2006 Oct; 163(10):1697-704; quiz 1858-9. PubMed ID: 17012676
    [No Abstract]   [Full Text] [Related]  

  • 14. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum levels of tumor necrosis factor-alpha in clozapine-associated obesity in chronic schizophrenia.
    Chen DC; Qi LY; Xiu MH; Cao LY; Wang F; Chen S; Wu GY; Kosten TA; Kosten TR; Zhang XY
    Schizophr Res; 2008 Dec; 106(2-3):367-8. PubMed ID: 18835132
    [No Abstract]   [Full Text] [Related]  

  • 17. Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions.
    Birkenaes AB; Birkeland KI; Engh JA; Faerden A; Jonsdottir H; Ringen PA; Friis S; Opjordsmoen S; Andreassen OA
    J Clin Psychopharmacol; 2008 Apr; 28(2):132-7. PubMed ID: 18344722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking and weight among patients using clozapine.
    Seppälä N; Leinonen E; Viikki M; Kampman O
    Nord J Psychiatry; 2014 Nov; 68(8):620-5. PubMed ID: 24802120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight gain associated with antipsychotic drugs.
    Ganguli R
    J Clin Psychiatry; 1999; 60 Suppl 21():20-4. PubMed ID: 10548138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agents.
    Spivak B; Musin E; Mester R; Gonen N; Talmon Y; Guy N; Roitman S; Kupchik M; Kotler M; Weizman A
    Int Clin Psychopharmacol; 1999 Jul; 14(4):229-32. PubMed ID: 10468315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.